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ABSTRACT 
Objectives: The limitation of therapeutic effort during end-of-life care has been object of an 
intense debate throughout the medical community. The aim of this study was to analyse the 
different perspectives of medical students regarding these topics and identify characteristics 
associated with them. Methods: Q methodology analysis was performed to find profiles. A 
chi-square test was used to compare proportions. Results: 143 students participated. We 
obtained three opinion profiles. The first of the profiles seeks to ensure quality of life and 
attaches great importance to the patient’s will; the second one puts life extension above 
anything else; and the third one advocates an equitable health system with no room for 
special cases. Those students who have religious beliefs are included in profile 2 in a greater 
proportion (48.8% vs 27.5%), while those who claim not to be religious or consider their 
beliefs do not influence their ethical principles are primarily included in profile 3 (48.5% vs 
29.2%). Conclusion: Three profiles were identified on end-of-life care. Given the influence of 
beliefs and academic training on these viewpoints, the reinforcement of bioethics and health 
economics contents in medical schools’ curricula would contribute to developing more 
knowledge-based opinion profiles. 
Keywords: end-of-life care, medical students, opinion profile, Q methodology. 
 
RESUMEN 
Objetivos: La limitación del esfuerzo terapéutico en el contexto de los tratamientos de 
soporte al final de la vida ha generado un intenso debate en la comunidad médica. El objetivo 
de este estudio fue analizar los diferentes puntos de vista de los estudiantes de medicina 
sobre estos temas, e identificar características asociadas con los mismos. Métodos: Se realizó 
un análisis con metodología Q para hallar perfiles. Para comparar proporciones se utilizó un 
test chi-cuadrado. Resultados: 143 estudiantes participaron. Se obtuvieron tres perfiles de 
opinión. El primero de ellos busca garantizar la calidad de vida y el respeto a la voluntad del 
paciente; el segundo valora la extensión de la vida por encima de todo; y el tercero aboga por 
un sistema de salud equitativo, sin espacio para casos especiales. Los estudiantes que tienen 
creencias religiosas se incluyen en el perfil 2 en una mayor proporción (48.8% vs 27.5%), 
mientras que aquellos que no son religiosos o consideran que sus creencias no influyen sus 
principios éticos pertenecen principalmente al perfil 3 (48.5% vs 29.2%). Conclusión: Tres 
perfiles con respecto a los tratamientos de soporte al final de la vida fueron identificados. 
Considerando la influencia de las creencias y la formación académica en estos puntos de vista, 
el refuerzo de los contenidos de bioética y economía sanitaria en las facultades de medicina 
contribuiría a desarrollar perfiles de opinión más basados en el conocimiento. 
Palabras clave: tratamientos de soporte al final de la vida, estudiantes de Medicina, perfil 
de opinión, metodología Q. 
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Over the last decades life expectancy at birth in developed countries has increased gradually, 
and recent prospective studies show that it will keep increasing.1 Advances in Medicine have 
provided us with tools that allow us to extend life in critical situations and, as a consequence, 
and together with the generalised declining birth rate, societies are experiencing a 
progressive ageing of population.2,3 
The fact that we can artificially prolong life led to the emergence of a bioethical debate about 
the issue, which is still present today.4 On the other hand, from an economic point of view, 
our limited resource system faces a great challenge, since global spending on health is 
expected to greatly increase in the next decades.5  
Regarding bioethics and health economy, one of the most controversial issues over the last 
years has been the end-of-life care and the limitation of therapeutic effort. When life is 
coming to an end, it is important to feel comfortable and die with dignity, but there are 
different opinions on how and when we should let nature take its course.2,4,6–8 
The limitation of therapeutic effort consists in deciding on the status and future of the patient 
to not apply treatments or therapeutic procedures that will provide little benefit about the 
suffering or agony the patient is experiencing.8 Despite being well defined, there are many 
conditioning factors that may influence when time for decision making comes, most of them 
subjective and personal. In this context, training in bioethics and health economics could play 
a modulating role of the behaviours and attitudes of healthcare professionals regarding end-
of-life care.  
In Spanish medical schools, training in bioethics is usually limited to several lectures during 
one of the last years.9,10 An analysis of different teaching-learning strategies in bioethics 
suggested that, in order to help medical students confronting ethical dilemmas, bioethics 
should become a transverse axis of the curriculum, from a multidisciplinary approach.11 In the 
same manner, and noting that many medical schools do not routinely cover health economics 
in the curriculum,12 it has been strongly recommended that medical students receive an 
adequate formation in this subject,13 since the foundation of resource allocation is entwined 
with key ethical principles of distributive justice.14 
The aim of this study was to identify medical students’ different views on end-of-life care and 
to assess whether these views changed depending on factors related to the level of studies 
achieved and their background (convictions and experience with terminal patients). 
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The design of our study involved, on the one hand, the development of a Q methodology 
study15 in order to identify the views on end-of-life care in a medical students sample and, on 
the other hand, the analysis of the factors associated with the different profiles identified. 
Q METHODOLOGY 
Q methodology provides a scientific basis for the systematic study of subjectivity, identifying 
similarity patterns after the classification of a set of statements by respondents, a process 
known as “Q-sort.”15,16 
To create a Q methodology survey, the following steps were performed. First of all, a set of 
statements of opinion was obtained, being the main element from which the study was then 
developed. After that, the selected study population was invited to participate. Finally, an 
analysis of the results obtained was performed, and the different patterns of opinion were 
identified and characterised. These steps are described in detail below. 
THE STATEMENT SET 
The first step consisted of obtaining a set of statements of opinion, representative of different 
views on situations relating with the provision of end-of-life treatments, which were 
presented to respondents so that they sorted them according to their ethical values and own 
experiences.  
A review of articles that evaluated opinions on end-of-life care was carried out. One study 
amongst the analysed literature stood out – McHugh et al., 2015, addressing societal 
perspectives about end-of-life care – since we considered that the set of statements they 
used fitted our requirements.17 A further selection was made, considering aspects such as the 
cultural differences between both workplaces and legislative and health policy differences. 
Those statements found repetitive, ambiguous or unclear were dismissed, resulting in a final 
set of 28 statements out of the 49 they used (see Table 1). 
STUDY POPULATION AND DATA COLLECTION 
The second step involved identifying respondents and sending them the survey.   
Our participants were selected amongst the University of Cantabria’s School of Medicine’s 
students. Students from each of the six years of the degree were asked to participate in the 
study and share the link to the online questionnaire with their classmates, via email and 
WhatsApp. The link was active from November 2019 until January 2020.  
The questionnaire had three sections. In the first section, students had to complete an 
informed consent in order to participate in the study. The second section consisted of the Q 
sets explained above. Finally, the third section of the questionnaire, was composed of a set 
of socio-demographic questions which included age, gender and year of studies. In addition, 
respondents were asked for their average grade and parents’ education level. Questions 
about religion, personal experiences with terminal patients – either as a relative or as a friend 
–, and hospital contact with these kind of patients as a student, were introduced as well. 
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Finally, respondents were asked about the influence they considered these factors might have 
in their current views and thoughts towards end-of-life care. 
The questionnaire was built in an online-based platform in order to make the handling of Q-
sorts easier (which frequently involves rethinking and changing positions between previously 
sorted statements)18 and thus, improve participation. To this end, we used Easy-HtmlQ (an 
open source licence app developed in HTML5 and JavaScript). An adaptation was made on 
the platform to allow the inclusion of the informed consent at the beginning and the set of 
socio-demographic questions at the end. In addition, a brief explanation was included before 
every part of the survey. The Easy-HtmlQ online platform was deployed using, on the one 
hand, Netlify web hosting services and, on the other hand, Google’s Firebase tool for storing 
data.  
Then, the Q-sort process started, first by classifying the set of statements, based on whether 
they agreed, disagreed, or had a neutral opinion about them. It was not until they classified a 
sentence that they could read the following one, so that they focused on each one separately 
and not as a whole. 
In the next step, respondents were asked to sort and position these statements on a response 
grid, known as “Q-grid” (see Figure 1). They started by ranking the statements with which 
they had previously agreed. First, they chose those two statements with which they agreed 
the most (+3), following with the four which they considered to be +2 and ending with the 
five statements for the +1 position. The same process took place from the left side, placing 
the previously classified as disagree statements in the -3, -2 and -1 columns.  
In the end, the remaining statements, those that had been sorted as neutral, were placed in 
the 0 position. However, in most cases there were not the same number of 0 spots than of 
statements marked as neutral; sometimes there were more than 6 neutral statements and, 
in other cases, there were more agree or disagree statements than positions for them. When 
this happened, they had to place the statements in the remaining places. This last step of the 
Q-sort ensured that respondents had to double-check their previous choices, since they were 
forced to decide which sentence deserved the most each place, even if previously they had 
sorted them as equals. 
STATISTICAL ANALYSIS  
The Q method analysis was performed in Ken-Q Analysis v1.0.3, a specific Web Application 
for Q Methodology.19 The analytical process involved two parts. Firstly, a principal component 
analysis (PCA) was done, in which the respondents (instead of the variables) are correlated in 
order to identify the number of natural grouping of Q sort. Secondly, a particular Q method 
analysis was developed. This analysis consisted of three phases: (1) flagging the Q sort that 
defines each factor, (2) calculating the score of statements for each factor and (3) finding the 
distinguish and consensus statements. The standard analytical process in Q methodology has 
been previously described in detail.20,21 
Finally, after defining the different opinion patterns, a chi-square test was performed to 
identify the factors related to each pattern. This statistical analysis was developed with the 
statistical package STATA vs 16.0. 
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STUDY POPULATION 
The link to the survey was distributed amongst the students of the six years of the degree 
(773 in total), obtaining 143 responses, which means a response rate of 18.5%. The 
characteristics of the 143 respondents are presented in Table 2. Mean age was 22.1 (SD: 2.68) 
years. About a third of participants (29.4%) were in first, second or third year of their medical 
studies, whereas the remaining two thirds (70.6%) were in fourth, fifth or sixth year. 98 out 
of the 143 (68.5%) respondents were women. As for the students’ origin, 54.5% came from 
Cantabria, and the rest were distributed amongst other 26 Spanish provinces, mostly from 
Asturias (14%) and Madrid (4.9%). 
FACTORS 
We selected the three factors explaining more variance (56%); all these factors were 
interpretable, so from here on we will refer them as profiles 1, 2 and 3. 121 respondents 
(84.6% of the sample) could be included in one of these profiles and 22 (15.4%) could not be 
classified so they were excluded from the statistical analysis. 
Profiles are characterized by the statements that distinguish one from another; from here on, 
each statement will be presented followed by its number, its position on the Q-grid (from -3 
to +3), and an * in case of a distinguishing factor, as done in other studies.17,22 For instance, 
when describing profile 1, we use  (#5, 0*), which indicates that it is statement #5 in Table 3 
(“I would place more value on end-of-life treatments than many medical treatments for non-
terminal conditions”); it has scored 0 in people with profile 1 and this sentence allows to 
distinguish this profile from profiles 2 and 3. There are just two out of the 28 presented 
statements to which all factors showed the same level of agreement. Depending on the 
difference of the Z-score value between the three factors, we can consider these statements 
as consensus statement or not.23 For example, in #4: “It is important to give a dying person 
and their family time to prepare for their death, put their affairs in order, make peace and say 
goodbyes”, the three factors agreed with +2, and the difference of the Z-score between them 
was only of 0.16, so we identified it as a consensus statement.  
FACTOR 1: EXTENDING LIFE – PATIENT’S WILL AND QUALITY OF LIFE 
The first of the three factors accounts for 17.5% of the sample (25 respondents). Figure 2 
shows the composite Q-sort for this group. 
People holding this view are distinguished from the rest in the fact that they do not express 
preference in statements that are closely related to will or perceptions of the terminal 
patients or their relatives: “Extending life for people with terminal illnesses is only postponing 
death” (#21, 0*) or “I would place more value on end-of-life treatments than many medical 
treatments for non-terminal conditions” (#5, 0*). They worry about the patient’s will, 
respecting their power to decide about their own life: “If somebody wants to keep fighting 
until the last possible moment, they should be allowed to do so, regardless of cost” (#3, 2).  
They neither defend life at any cost: “Life is sacred and if it is possible to preserve life, every 
effort should be made to do so” (#22, -3); “It is human nature to want to preserve life and go 
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on living for as long as we can – it is one of our most basic instincts” (#7, -1*), nor would 
encourage a terminal patient to prolong his life unless ensuring a good quality of life: “Real 
help and compassion should be about providing a death with dignity instead of more drugs 
to get a few more weeks or months out of a very sick body” (#11, 2).  
This view leaves the economic matter into the background, justifying any treatment 
regardless of how expensive it might be: “Everyone has a right to basic healthcare but there 
has to be limits and expensive, end-of-life, drugs are not basic care” (#24, -3*); “Expensive 
drugs for people who are terminally ill and won’t benefit very much are not a good use of 
public funding” (#6, -2); “Treatments that are very costly in relation to their health benefits 
should be withheld” (#17, -2).  
Finally, respondents of this group show a special sensitivity towards terminal patients: “I think 
life-extending treatments for people who are terminally ill are of less value as people get 
older” (#26, -2).  
In summary, this group is characterised for respecting the patient’s decisions, worrying about 
their quality of life, not just the extension, and justifying any health expenditure related with 
end-of-life care provided that the patient approves it. 
FACTOR 2: EXTENDING LIFE – AT ALL COSTS 
The second factor accounts for 29.4% of the sample (42 respondents). Figure 3 shows its 
composite Q-sort. 
People with this view advocate life extension in any case: “It is human nature to want to 
preserve life and go on living for as long as we can – it is one of our most basic instincts” (#7, 
2*); “If the means of helping someone live longer exists, it is morally wrong to deny them the 
treatment” (#15, 2*); “Extending life for people with terminal illnesses is only postponing 
death” (#21, -3*). 
They defend life at any cost: “If somebody wants to keep fighting until the last possible 
moment, they should be allowed to do so, regardless of cost” (#3, 2). In contrast to the other 
views, they reject euthanasia since it is presented as a measure of health expenditure control, 
and this is not a primary concern for them: “An objective measure of health expenditure 
control could be to legalize the euthanasia process” (#28, -1*). 
Consequently, respondents included in this profile maintain that every effort should be made 
to prolong life, even if it is for a short time: “It may not sound like much, but a few extra weeks 
or months might mean an awful lot to a family affected by a terminal illness” (#9, 3*); “It´s 
important to provide life-extending treatments to give a dying person time to reach a 
significant milestone, like a family event or a personal achievement” (#25, 1*); “Treatments 
that provide a short life extension are not worth it – they are only prolonging the pain for the 
patient’s family/friends” (#20, -3*); “End-of-life drugs are not a cure, they are life-prolonging. 
There is no point in delaying the inevitable for a short time” (#18, -2*); “Patients at the end 
of life will grasp any slightest hope but that is not a good reason for the NHS to provide costly 
treatments that may extend life by a short time” (#19, -2*). 
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In the same manner as people from profile 1, they consider terminal patients are worthy of a 
special attention, even if they accept that despite greater spending, important health gains 
are not expected: “Treatments that are very costly in relation to their health benefits should 
be withheld” (#17, -2); “I think life-extending treatments for people who are terminally ill 
are of less value as people get older” (#26, -2). 
Due to the force of the next two statements, and despite people from this group do not agree 
with them, the fact that they do not even reject them is an indicator of how much they respect 
life: “Not giving access to life-extending medicine to a person with a terminal illness is the 
same as killing them” (#16, 0*); “Life is sacred and if it is possible to preserve life, every effort 
should be made to do so” (#22, 0*). 
Respondents included in this profile do not show a clear position (neither agreement nor 
disagreement) in those statements aimed at evaluating the expected quality of life of a 
patient with a terminal illness. In this case, similarly as the previous paragraph, the fact that 
they do not reject them suggest that they prioritise life extension rather than quality of life: 
“At the end of their life, patients should be cared for at home with a better quality of life 
rather than have aggressive and expensive treatments that will only extend life for a short 
period of time” (#2, 0*); “Life should only be extended if the patient's quality of life during 
that time will be good” (#10, 0*); “Real help and compassion should be about providing a 
death with dignity instead of more drugs to get a few more weeks or months out of a very 
sick body” (#11, 0*).  
Finally, when the moral problem of prolonging the life of a terminally ill patient ("Prolonging 
life in a beneficial way for the patient is morally correct") is assessed, this profile does not 
show a clear position (#14, 0*). In contrast, respondents in the other two profiles strongly 
disagree with this statement 
In conclusion, this account is based on a deep respect of life, setting economic aspects aside, 
and leaving the principles of distributive justice in the background. People included in this 
group consider that every available treatment should be provided, regardless of its cost and  
the inequalities it might cause in the Public Health System. 
FACTOR 3: EXTENDING LIFE – HEALTH EQUITY, NO SPECIAL PATIENTS 
The third factor is the one that includes more respondents, accounting for 37.8% of the 
sample (54 participants). Figure 4 shows the composite Q-sort for factor 3. 
The main difference of this profile with the other two is the fact that they consider that the 
Public Health System must be equal to everyone, denying special benefits to terminal 
patients: “Patients at the end of life will grasp any slightest hope but that is not a good reason 
for the NHS to provide costly treatments that may extend life by a short time” (#19, 1*) ; “I 
would place more value on end-of-life treatments than many medical treatments for non-
terminal conditions” (#5, -2*);  “If somebody wants to keep fighting until the last possible 
moment, they should be allowed to do so, regardless of cost” (#3, -1*). Despite this group’s 
perspective, which focuses more on the whole population rather than the individual, they do 
not put aside the patient’s will: “Patients should have the right to refuse life-extending 
treatments if they choose” (#1, 3*).  
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In addition, they do not express a preference regarding the sentences that imply a greater 
expenditure in end-of-life care: “If a life-extending treatment for terminally ill patients is 
expensive, but the only treatment available, it should still be provided” (#8, 0*); “We should 
spend proportionately more on patients when we feel those patients have not had their fair 
innings – in terms of the length of their life or the quality of that life” (#13, 0*); “Treating 
people at the end of life is not going to result in big health gains but the health system should 
be about looking after those patients in greatest need” (#27, 0*). 
Unlike respondents from profile 2, people included in this profile strongly reject to extend life 
just to keep the patient alive, disagreeing with the statements which advocate this idea: “Life 
is sacred and if it is possible to preserve life, every effort should be made to do so” (#22, -3); 
“A year of life is of equal value for everyone” (#12, -3*); “Not giving access to life-extending 
medicine to a person with a terminal illness is the same as killing them” (#16, -2*); “To extend 
life in a way that is beneficial to the patient is morally the right thing to do” (#14, -2). 
On the other hand, respondents from this group present some similarities with group 1, since 
they consider that life extension is only worth and ethic if it results in actual health gains, not 
just stopping death from happen: “I wouldn’t want my life to be extended just for the sake of 
it – just keeping breathing is not life” (#23, 3);  and provided quality of life will be good: “Life 
should only be extended if the patient’s quality of life during that time will be good” (#10, 2); 
“Real help and compassion should be about providing a death with dignity instead of more 
drugs to get a few more weeks or months out of a very sick body” (#11, 2). 
In summary, this group of respondents show a more societal viewpoint if compared to the 
other two, giving more importance to the population as a whole, making sure everyone gets 
the same benefits from the Health System, than individualising to each patient’s situation. 
Besides, they advocate for maintaining a good quality of life and respecting patient’s will 
during their last days. 
CHARACTERISTICS ASSOCIATED WITH THE PROFILES 
Respondents’ characteristics associated with the profiles are presented in Table 4.  
The only two variables that were found to be significantly associated with the profiles were 
the respondents’ religious beliefs and the influence they considered these beliefs carried on 
their ethical principles. Those students who profess to have religious beliefs are included in 
profile 2 in a much greater proportion (48.8% vs 27.5%), while those who claim not to be 
religious or consider their beliefs do not influence their ethical principles are included in a 
greater proportion in profile 3 (48.5% vs 29.2%). 
In addition, we identified some aspects that showed important differences in their 
distribution between the profiles, although without reaching statistical significance.  
Regarding the influence of the academic record, the third profile predominates in last-year 
students (56.5%), as well as in those respondents with the highest average grade (>8/10) 
(60.0%). On the other hand, students who reported previous experiences with terminally ill 
patients during their clerkship belong to the first profile in a greater proportion (25.0% vs 
17.5%). Those who considered that their personal experiences influenced their attitude 
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towards end-of-life care show a clear predominance of profile 2 (45.5%), while those who 
were not influenced by this factor are in profile 3 in a greater proportion (52.2%). 
Those respondents whose two parents completed university studies are evenly distributed 
amongst profile 2 and 3; however, in those cases when one of the parents did not achieve 
university studies profile 3 predominates. The third profile also predominates in students 
living with their families (49.1%) and in those who have not had any contact with terminal 
patients during their clinical clerkship (47.5%).  
No differences associated to sex or age were found. 
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The aim of our study was to identify and describe the different views of our Medical School 
students towards end-of-life care, assessing the relative value of highly cost treatments for 
terminally ill patients and exploring the students’ perspective about the ethical and moral 
dilemmas that these topics bring about. 
Our study identified three main profiles amongst the students’ opinions. The first view 
(extending life – patient’s will and quality of life) leaves in the background health economics 
and focuses on respecting the patient’s choice regarding his own life, provided the expected 
quality of life is good. The second profile (extending life – at all costs) is similar to the previous 
one regarding economic aspects, since they spare no expenses on treatments for terminally 
ill patients; however, people conforming this view think every patient should have the chance 
to prolong his life to the limit, leaving the quality aspect aside. The last profile (extending life 
– health equity, no special patients) differs from the previous two on their economic outlook: 
they support an equal system to every patient, in which nobody deserves being treated as 
different or special, regardless of their condition. In this respect, and in contrast with the 
other two profiles, they advocate a greater control of health expenditure and support the 
limitation of therapeutic effort. Nevertheless, they resemble the first profile in the sense that 
they show a great respect for the patient’s will and are great defenders of a good quality of 
life 
On the other hand, we identified one consensus statement (#4). Consensus factors usually 
identify those situations that are always difficult to accept or reject, regardless of that group's 
opinion about the rest of presented matters, but they also identify ambiguous statements or 
even situations in which respondents do not want to express commitment because they 
tackle taboo issues.23 After analysing the different profiles, we realised that this consensus 
statement lacked all the ideas that provoked rejection or acceptance towards the rest of the 
statements, since it does not asses economic (cost of care) or moral aspects (preservation of 
lifetime). Furthermore, it accepts death, showing an empathic view towards the dying person, 
which makes it difficult for everyone to disagree.  
Consistently with our results, several studies assessing end-of-life care beliefs17,22,24 identified 
similar profiles. McHugh et al., described a group of people in which “patients’ rights are 
central and life is regarded as precious and priceless so even high cost treatments that deliver 
limited benefits should not be withheld from patients”, and another group whose main view 
was “to achieve the greatest health gains for the greatest number through the efficient 
allocation of limited resources”, which clearly correspond to our factors 2 and 3. They also 
described a third group of people for whom quality of life was one of their main concerns, 
similarly as respondents included in our first profile, but it differed from ours on the patient’s 
will aspect. In our study, this profile prioritizes the patient’s willingness – justifying the 
provision of any possible treatment if the patient asks for it. In contrast, the third profile 
identified by McHugh et al. focuses only on the quality of life aspect.17 In the same line, 
Wouters et al.22, also described three profiles. Two of them are similar to our profiles 1: “the 
care that terminal patients receive should at all times respect the patients’ quality of life and 
dignity” and 3, which emphasizes “the importance of equality in opportunities and hence 
access to healthcare” and “denies giving priority in any circumstance, because assigning 
priority to some patients at the cost of others conflicts with every person’s basic and equal 
right to healthcare”. The remaining profile focuses on cost-effectiveness, considering it the 
main criterion for decision-making. This aspect could fit in the description of our third profile; 
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nevertheless, people included in this profile “have no moral objection to priority setting”, and 
“believe that priority should be given to treatments that generate the most health and 
patients who benefit most from treatment”, which is clearly opposite to our third profile and 
to the similar one they described.22 Finally, Van Exel et al., identified 5 viewpoints, being three 
of them very similar to our profiles 1: “Quality of life is more important than simply staying 
alive”, 2: “The intrinsic value of life and healthy living”, and 3: “Egalitarianism, entitlement 
and equality of access”. The other two profiles they found were based on the magnitude of 
health gains and the relevance of patient’s age in priority setting.24 The fact that their sample 
was composed of people from ten different countries with a wide age range and varying 
socio-economic and health status, as well as the larger set of statements (34 vs 28) they used, 
probably increased the variability of opinions, and may be the reason why they described five 
different profiles. 
Finally, the factors associated with these three profiles were identified. Students about to 
complete their medical degree have already received training in bioethics and spend most of 
the year performing their clinical clerkship, which puts them in contact with the actual 
situation of the National Health System. This first contact has been suggested to be the most 
powerful factor that influences self-perceived attitudes towards end-of-life care.25 In our 
case, we found that respondents who reported previous contact with terminal patients were 
included in profile 1 (extending life – patient’s will and quality of life) in a greater proportion 
than those who did not have previous experiences with these patients. This profile focuses 
on preserving quality of life, an aspect that medical students do not contemplate until they 
complete their clinical training and start dealing with patients. In this respect, a more in-
depth, standardized practical training for medical and nursing students has been considered 
to be necessary in order to ensure an adequate end-of-life care provision, especially regarding 
the humane component and empathy that professionals must show.26 A previous study 
assessing medical students’ views on the development of empathic behaviour towards 
patients revealed that early patient contact and clinical skills and communication courses 
were found by the students to be very helpful in order to foster their ability to empathise with 
patients.27 
Respondents who claimed to be religious were found to be more likely included in the second 
profile (extending life – at all costs) than in the other two. In this regard, only those amongst 
this group who were practising and considered their religious beliefs to influence their view 
on end-of-life care were more likely to find themselves in the second profile, whereas the 
ones who considered not being influenced by religion were predominantly included in the 
third profile. Given that more than 60% of Spanish population declare to be Catholic – 
although just around 20% are practising – ,28 we will discuss the results referring to this 
religion. People included in this profile support preservation of life in any case, regardless of 
the patient’s condition, which concurs with the defence of life that Christianity advocates, 
presenting life as a gift from god which has to be protected.29 Only one study using Q 
methodology analysed the influence of religion and suggested that participants who place a 
high value on life might be influenced by their religious beliefs.24 In the same line, studies 
using other methodologies have shown that medical students who state to have an active 
religious belief are likely to disagree with actions that hasten death,30 consistently with the 
findings of our study. 
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In this connection, it has been suggested that being a last-year student is associated with a 
greater likelihood of agreeing with actions that precipitate death in a terminally ill patient,30 
which concurs with our third profile (extending life – health equity, no special patients). The 
fact that more than half of the last-year students (56.5%) were included in this profile could 
be partially explained by the influence of the knowledge acquired through their degree. It can 
be speculated that, as a result of a six-year process of knowledge acquisition, students 
incorporate economic aspects in their overall viewpoint of health. In this line, they believe 
that the Public Health System must maximise the whole population’s health gains, promoting 
an equitable public funds allocation and an adequate provision of end-of-life care. It has been 
suggested that a formal curriculum in health systems and health policy should be an essential 
component of medical education, and that students should be provided with this training 
prior to their third year, so that they can integrate their clinical experiences into a broader 
framework.31 A review of the literature on health policy training revealed that most 
programmes focused exclusively on the impact of health policy training in the context of 
health care. Therefore, the reviewers urged to widen the scope and consider taking into 
consideration public health and the spectrum of non-health sectors that impact population 
health as well.32  
LIMITATIONS AND STRENGTHS 
There are some limitations in our study that should be mentioned. Firstly, since our sample is 
composed exclusively of students from a single medical school, it might seem that the results 
obtained cannot be applicable to the whole Spanish medical student population. However, 
curricula and study programmes throughout the country are very similar. In addition, those 
of newly opened centres, must be approved by a national agency (ANECA, National Agency 
for Quality Assessment and Accreditation), member of the European and International 
Association for Quality Assurance in Higher Education, in order to ensure equality and 
standardisation between graduates of every school.10,33 Therefore, we believe that the 
medical students of our School represent quite well the Spanish community of medical 
students. Secondly, the low participation rates of students in the lower years prevents us from 
exploring in detail how being in a particular year of the degree determines the profile. 
However, we were able to separately analyse the role of clinical experience, because more 
than half the students in the last year of the degree participated in the survey. This matter is 
especially relevant given that one of our objectives was to study the influence of clinical 
experience in the attitudes towards the terminally ill. Thirdly, statistical power was limited for 
the analyses of associated factors, due to the small number of exposed in some of the 
different subgroups. However, this issue did not affect the Q methodology analysis. Despite 
the low response rate, the characteristics of the study population were not altered in the 
sample, since the proportion of women was similar (68.5% in the sample vs 71.7% in the 
population) and we obtained questionnaires from respondents of 27 different Spanish 
provinces, since our medical school attracts students from other parts of Spain. 
To the best of our knowledge, this is the first time that a study evaluates opinions on bioethics 
and end-of-life care applying Q methodology to a sample composed exclusively of medical 
students. This strategy allows an in-depth analysis of the different profiles of medical students 
on a matter we consider of crucial importance on their future professional life.  
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Previous studies have used more heterogeneous samples, assessing students’ views but also 
those of others members of the public, such as researchers and health policy makers, which 
may mask students’ opinion on the matter.34 Similar studies have highlighted the need for 
further research on students’ perception of end-of-life care, as well as medical schools’ 
approach to the subject.35–37 
Although other methodologies have proven to be useful for studying public views on end-of-
life care and health economics,38 such as budget allocation39,40 or willingness-to-pay,41,42 we 
picked Q methodology since we wanted to obtain a broader view of the different patterns of 
opinion amongst the students. Achieving this goal would have been difficult using any of the 
other methodologies, considering that they mostly explore specific scenarios. 
CONCLUSION 
Three different viewpoints on end-of-life care amongst medical students have been revealed 
in this study. These profiles are influenced by personal factors (beliefs, experience with 
terminally ill patients) and other aspects related to the academic training received. Taking 
these results into account, the reinforcement of bioethics and health economics, often 
overlooked in medical schools’ curricula, would contribute to developing more 
knowledgeable opinion profiles, instead of students relying on personal experiences on these 
topics.  
These two areas of knowledge are of essential significance in order to help our medical 
students – and the future professionals who they will shortly become – to deal with difficult 
situations related to the topics we have addressed. We also need to bear in mind that these 
are the professionals that will most likely contribute to creating policies that regulate matters 
as complex as end-of-life care. Hence, training in these areas should be considered a priority 
by the whole academic and medical community. 
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1. Patients should have the right to refuse life-extending treatments if they choose. 
2. At the end of their life, patients should be cared for at home with a better quality of life rather than have aggressive and expensive treatments 
that will only extend life for a short period of time. 
3. If somebody wants to keep fighting until the last possible moment, they should be allowed to do so, regardless of cost. 
4. It is important to give a dying person and their family time to prepare for their death, put their affairs in order, make peace and say goodbyes.  
5. I would place more value on end-of-life treatments than many medical treatments for non-terminal conditions. 
6. Expensive drugs for people who are terminally ill and won’t benefit very much are not a good use of public funding.  
7. It is human nature to want to preserve life and go on living for as long as we can - it is one of our most basic instincts  
8. If a life-extending treatment for terminally ill patients is expensive, but the only treatment available, it should still be provided  
9. It may not sound like much, but a few extra weeks or months might mean an awful lot to a family affected by a terminal illness  
10. Life should only be extended if the patient's quality of life during that time will be good. 
11. Real help and compassion should be about providing a death with dignity instead of more drugs to get a few more weeks or months out of a very 
sick body. 
12. A year of life is of equal value for everyone. 
13. We should spend proportionately more on patients when we feel those patients have not had their fair innings - in terms of the length of their 
life or the quality of that life. 
14. To extend life in a way that is beneficial to the patient is morally the right thing to do. 
15. If the means of helping someone live longer exists, it is morally wrong to deny them the treatment. 
16. Not giving access to life-extending medicine to a person with a terminal illness is the same as killing them. 
17. Treatments that are very costly in relation to their health benefits should be withheld. 
18. End-of-life drugs are not a cure, they are life-prolonging. There is no point in delaying the inevitable for a short time. 
19. Patients at the end of life will grasp any slightest hope but that is not a good reason for the NHS to provide costly treatments that may extend life 
by a short time. 
20. Treatments that provide a short life extension are not worth it - they are only prolonging the pain for the patient’s family/friends. 
21. Extending life for people with terminal illnesses is only postponing death. 
22. Life is sacred and if it is possible to preserve life, every effort should be made to do so. 
23. I wouldn’t want my life to be extended just for the sake of it - just keeping breathing is not life. 
24. Everyone has a right to basic healthcare but there has to be limits and expensive, end-of-life, drugs are not basic care. 
25. It's important to provide life-extending treatments to give a dying person time to reach a significant milestone, like a family event or a personal 
achievement. 
26. I think life-extending treatments for people who are terminally ill are of less value as people get older. 
27. Treating people at the end of life is not going to result in big health gains but the health system should be about looking after those patients in 
greatest need. 
28. An objective measure of health expenditure control could be to legalize the euthanasia process. 
 Table 1. Set of statements. 
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                                           Figure 1. Q-grid. 
 
Variable Category 
All respondents N=143 
N(%) 
Respondents with profile 
N=121 N(%) 
Gender 
Male 45(31.47) 39(32.23) 
Female 98(68.53) 82(67.77) 
Year of 
studies 
First to third-
grade students 
42(29.37) 37(30.58) 
Fourth to fifth-
grade students 
48(33.57) 38(31.40) 
Sixth-grade 
students 
53(37.06) 46(38.02) 
Start year 
2013 8(5.59) 6(4.96) 
2014 50(34.97) 44(36.36) 
2015 26(18.18) 22(18.18) 
2016 15(10.49) 11(9.09) 
2017 19(13.29) 17(14.05) 
2018 15(10.49) 11(9.09) 
2019 10(6.99) 10(8.26) 
Origin 
Another 
province 
65(45.45) 57(47.11) 
Cantabria 78(54.55) 64(52.89) 
Age 
(mean(sd)) 
 22.13(2.68) 21.97(2.37) 
Completion 
time in 
seconds 
(mean(sd)) 
 985.01(431.28) 967.46(407.89) 
Table 2. Sample characteristics. 
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Statement F1 F2 F3 
1. Patients should have the right to refuse life-extending treatments if they choose. 3 3 3* 
2. At the end of their life, patients should be cared for at home with a better quality of life rather than have aggressive and expensive treatments 
that will only extend life for a short period of time. 1 0* 1 
3. If somebody wants to keep fighting until the last possible moment, they should be allowed to do so, regardless of cost. 2 2 -1* 
4. It is important to give a dying person and their family time to prepare for their death, put their affairs in order, make peace and say goodbyes 2 2 2 
5. I would place more value on end-of-life treatments than many medical treatments for non-terminal conditions. 0* -1 -2* 
6. Expensive drugs for people who are terminally ill and won't benefit very much are not a good use of public funding. -2 -1 0* 
7. It is human nature to want to preserve life and go on living for as long as we can - it is one of our most basic instincts -1* 2* 1 
8. If a life-extending treatment for terminally ill patients is expensive, but the only treatment available, it should still be provided 1 1 0* 
9. It may not sound like much, but a few extra weeks or months might mean an awful lot to a family affected by a terminal illness 2 3* 2 
10. Life should only be extended if the patient's quality of life during that time will be good. 1 0* 2 
11. Real help and compassion should be about providing a death with dignity instead of more drugs to get a few more weeks or months out of a 
very sick body. 2 0* 2 
12. A year of life is of equal value for everyone. -2 -1 -3* 
13. We should spend proportionately more on patients when we feel those patients have not had their fair innings - in terms of the length of their 
life or the quality of that life. 1 1 0* 
14. To extend life in a way that is beneficial to the patient is morally the right thing to do. -1 0* -2 
15. If the means of helping someone live longer exists, it is morally wrong to deny them the treatment. 0 2* -1 
16. Not giving access to life-extending medicine to a person with a terminal illness is the same as killing them. -1 0* -2* 
17. Treatments that are very costly in relation to their health benefits should be withheld. -2 -2 -1 
18. End-of-life drugs are not a cure, they are life-prolonging. There is no point in delaying the inevitable for a short time. -1 -2* -1 
19. Patients at the end of life will grasp any slightest hope but that is not a good reason for the NHS to provide costly treatments that may extend 
life by a short time. -1 -2* 1* 
20. Treatments that provide a short life extension are not worth it - they are only prolonging the pain for the patient's family/friends. 0 -3* -1 
21. Extending life for people with terminal illnesses is only postponing death. 0* -3* -2 
22. Life is sacred and if it is possible to preserve life, every effort should be made to do so. -3 0* -3 
23. I wouldn't want my life to be extended just for the sake of it - just keeping breathing is not life. 3 1 3 
24. Everyone has a right to basic healthcare but there has to be limits and expensive, end-of-life, drugs are not basic care. -3* -1 0* 
25. It's important to provide life-extending treatments to give a dying person time to reach a significant milestone, like a family event or a 
personal achievement. 0 1* 1 
26. I think life-extending treatments for people who are terminally ill are of less value as people get older. -2 -2 0* 
27. Treating people at the end of life is not going to result in big health gains but the health system should be about looking after those patients in 
greatest need. 0 1 0* 
28. An objective measure of health expenditure control could be to legalize the euthanasia process. 1 -1* 1 
Table 3. Factor scores per statements. 
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Figure 2. Composite Q-sort for Factor 1. 
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Figure 3. Composite Q-sort for Factor 2. 
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Figure 4. Composite Q-sort for Factor 3. 
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  Profile  
Variable Category 
Extending life 
– patient’s 
will and 
quality of life 
N(%) 
Extending 
life – at all 
costs N(%) 
Extending 
life – 
health 
equity, no 
special 
patients 
N(%) 
P-value 
Year of studies 
First to third-grade 
students 
9(24.32) 15(40.54) 13(35.14) 
0,258 Fourth to fifth-grade 
students 
7(18.42) 16(42.11) 15(39.47) 
Sixth-grade students 9(19.57) 11(23.91) 26(56.52) 
Average grade 
5-<7 5(15.63) 13(40.63) 14(43.75) 
0,444 
7-8 14(25.00) 19(33.93) 23(41.07) 
>8 4(16.00) 6(24.00) 15(60.00) 
Previous 
contact with 
terminally ill 
patients in 
clinical 
clerkship 
No (none or scarce) 14(17.50) 28(35.00) 38(47.50) 
0,634 
Yes (some or frequent) 7(25.00) 10(35.71) 11(39.29) 
Lives with 
family 
No 12(19.35) 25(40.32) 25(40.32) 
0,409 
Yes 13(22.03) 17(28.81) 29(49.15) 
Both parents 
with university 
studies 
No 12(18.46) 20(30.77) 33(50.77) 
0,342 
Yes 13(23.21) 22(39.29) 21(37.50) 
Religious 
beliefs 
No 22(27.50) 22(27.50) 36(45.00) 
0,012 
Yes 3(7.32) 20(48.78) 18(43.90) 
Influence of 
religious 
beliefs in 
ethical 
principles 
Never/Scarce/No/Not 
applicable/ 
24(24.74) 26(26.80) 47(48.45) 
0,001 
Yes/Sometimes/Always 1(4.17) 16(66.67) 7(29.17) 
Influence of 
personal 
experience 
with terminal 
patient in EoL 
care opinion 
Never/Not applicable 12(17.91) 20(29.85) 35(52.24) 
0,064 
Sometimes 5(15.63) 12(37.50) 15(46.88) 
Always 8(36.36) 10(45.45) 4(18.18) 
Gender 
Male 8(20.51) 13(33.33) 18(46.15) 
0,969 
Female 17(20.73) 29(35.37) 36(43.90) 
Age 
(mean(sd)) 
 22.42(3.74) 21.77(2.15) 21.91(1.67) 0,565 
Table 4. Respondents' characteristics associated with the profiles.                         (EoL: end-of-life) 
 
